Publications by authors named "Farrokh Modabber"

Claim this Profile
C
CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.
Seth G Thacker, Ian L McWilliams, Beatrice Bonnet, Lydia Halie, Serge Beaucage, Farrokh Modabber

PLoS Negl Trop Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.
Emily Rose Mears, Farrokh Modabber, Robert Don, George E Johnson

PLoS Negl Trop Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive review of cutaneous leishmaniasis in kerman province, southeastern iran-narrative review article.
Iraj Sharifi, Mohammad Reza Aflatoonian, Ali Reza Fekri, Maryam Hakimi Parizi, Abbas Aghaei Afshar, Farrokh Modabber

Iran J Public Health· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis.
Shantanabha Das, Anja Freier, Thouraya Boussoffara, Sushmita Das, Detlef Oswald, Farrokh Modabber

Sci Transl Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.
Piero Olliaro, Michel Vaillant, Byron Arana, Max Grogl, Farrokh Modabber

PLoS Negl Trop Dis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis.
Mohammad H Alimohammadian, Stephen L Jones, Haideh Darabi, Farhad Riazirad, Soheila Ajdary, Farrokh Modabber

Am J Trop Med Hyg· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
Shyam Sundar, Prabhat Kumar Sinha, Madhukar Rai, Deepak Kumar Verma, Kumar Nawin, Farrokh Modabber

Lancet· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leishmaniasis vaccines: past, present and future.
Farrokh Modabber

Int J Antimicrob Agents· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research priorities for neglected infectious diseases in Latin America and the Caribbean region.
Jean-Claude Dujardin, Socrates Herrera, Virgilio do Rosario, Jorge Arevalo, Marleen Boelaert, Farrokh Modabber

PLoS Negl Trop Dis· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006.
Iraj Sharifi, Ali Reza Fekri, Mohammad Reza Aflatoonian, Ali Khamesipour, Fereidoun Mahboudi, Farrokh Modabber

Int J Dermatol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration.
Ahmed Mudawi Musa, Sassan Noazin, E A G Khalil, Farrokh Modabber

Trans R Soc Trop Med Hyg· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis.
Sassan Noazin, Ali Khamesipour, Lawrence H Moulton, Marcel Tanner, Kiumarss Nasseri, Farrokh Modabber

Vaccine· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First generation leishmaniasis vaccines: a review of field efficacy trials.
Sassan Noazin, Farrokh Modabber, Ali Khamesipour, Peter G Smith, Lawrence H Moulton

Vaccine· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis.
Hashim Ghalib, Farrokh Modabber

Kinetoplastid Biol Dis· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006.
Farrokh Modabber, Pierre A Buffet, Els Torreele, Geneviéve Milon, Simon L Croft

Kinetoplastid Biol Dis· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited.
Susanne Nylén, Ali Khamesipour, Akram Mohammadi, Reza Jafari-Shakib, Liv Eidsmo, Farrokh Modabber

Vaccine· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for drug-refractory mucosal leishmaniasis.
Roberto Badaro, Iza Lobo, Alvaro Munos, Eduardo M Netto, Farrokh Modabber

J Infect Dis· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leishmaniasis vaccine candidates for development: a global overview.
Ali Khamesipour, Sima Rafati, Noushin Davoudi, Fereidoun Maboudi, Farrokh Modabber

Indian J Med Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia.
Iván D Vélez, Katherine Gilchrist, María P Arbelaez, Carlos A Rojas, Juan A Puerta, Farrokh Modabber

Trans R Soc Trop Med Hyg· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis.
Ali Khamesipour, Yahya Dowlati, Ali Asilian, Reza Hashemi-Fesharki, Amir Javadi, Farrokh Modabber

Vaccine· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis.
Mohammad Hossein Alimohammadian, Ali Khamesipour, Haiedeh Darabi, Alireza Firooz, Shirin Malekzadeh, Farrokh Modabber

Vaccine· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis.
Rhea N Coler, Yasir A W Skeiky, Karen Bernards, Kay Greeson, Darrick Carter, Farrokh Modabber

Infect Immun· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial.
Jackson Machado-Pinto, Jorge Pinto, Carlos Alberto da Costa, Odair Genaro, Marcos José Marques, Farrokh Modabber

Int J Dermatol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis